Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Murine gamma/delta-expressing T cells affect alloengraftment via the recognition of nonclassical major histocompatibility complex class Ib antigens

BR Blazar, PA Taylor, JA Bluestone, DA Vallera

Blood (1996) 87 (10): 4463–4472.

https://doi.org/10.1182/blood.V87.10.4463.bloodjournal87104463

Published: 1996

Journal Articles

In vivo inhibition of cytokine responsiveness and graft-versus-host disease mortality by rapamycin leads to a clinical-pathological syndrome discrete from that observed with cyclosporin A

BR Blazar, PA Taylor, A Panoskaltsis-Mortari, S Sehgal, DA Vallera

Blood (1996) 87 (9): 4001–4009.

https://doi.org/10.1182/blood.V87.9.4001.bloodjournal8794001

Published: 1996

Journal Articles

Lethal murine graft-versus-host disease induced by donor gamma/delta expressing T cells with specificity for host nonclassical major histocompatibility complex class Ib antigens

BR Blazar, PA Taylor, A Panoskaltsis-Mortari, TA Barrett, JA Bluestone, DA Vallera

Blood (1996) 87 (2): 827–837.

https://doi.org/10.1182/blood.V87.2.827.bloodjournal872827

Published: 1996

Journal Articles

Therapy for ongoing graft-versus-host disease induced across the major or minor histocompatibility barrier in mice with anti-CD3F(ab')2-ricin toxin A chain immunotoxin

DA Vallera, PA Taylor, A Panoskaltsis-Mortari, BR Blazar

Blood (1995) 86 (11): 4367–4375.

https://doi.org/10.1182/blood.V86.11.4367.bloodjournal86114367

Published: 1995

Journal Articles

In utero transfer of adult bone marrow cells into recipients with severe combined immunodeficiency disorder yields lymphoid progeny with T- and B-cell functional capabilities

BR Blazar, PA Taylor, DA Vallera

Blood (1995) 86 (11): 4353–4366.

https://doi.org/10.1182/blood.V86.11.4353.bloodjournal86114353

Published: 1995

Journal Articles

Coblockade of the LFA1:ICAM and CD28/CTLA4:B7 pathways is a highly effective means of preventing acute lethal graft-versus-host disease induced by fully major histocompatibility complex-disparate donor grafts

BR Blazar, PA Taylor, A Panoskaltsis-Mortari, GS Gray, DA Vallera

Blood (1995) 85 (9): 2607–2618.

https://doi.org/10.1182/blood.V85.9.2607.bloodjournal8592607

Published: 1995

Journal Articles

Interleukin-10 administration decreases survival in murine recipients of major histocompatibility complex disparate donor bone marrow grafts

BR Blazar, PA Taylor, S Smith, DA Vallera

Blood (1995) 85 (3): 842–851.

https://doi.org/10.1182/blood.V85.3.842.bloodjournal853842

Published: 1995

Journal Articles

Adult bone marrow-derived pluripotent hematopoietic stem cells are engraftable when transferred in utero into moderately anemic fetal recipients

BR Blazar, PA Taylor, DA Vallera

Blood (1995) 85 (3): 833–841.

https://doi.org/10.1182/blood.V85.3.833.bloodjournal853833

Published: 1995

Journal Articles

In vivo blockade of CD28/CTLA4: B7/BB1 interaction with CTLA4-Ig reduces lethal murine graft-versus-host disease across the major histocompatibility complex barrier in mice

BR Blazar, PA Taylor, PS Linsley, DA Vallera

Blood (1994) 83 (12): 3815–3825.

https://doi.org/10.1182/blood.V83.12.3815.3815

Published: 1994

Journal Articles

Rapamycin, a potent inhibitor of T-cell function, prevents graft rejection in murine recipients of allogeneic T-cell-depleted donor marrow [published erratum appears in Blood 1994 Jun 1;83(11):3424-5]

BR Blazar, PA Taylor, SN Sehgal, DA Vallera

Blood (1994) 83 (2): 600–609.

https://doi.org/10.1182/blood.V83.2.600.600

Published: 1994

Journal Articles

Promotion of murine marrow alloengraftment and hematopoietic recovery across the major histocompatibility barrier by administration of recombinant human interleukin-1 alpha [see comments]

BR Blazar, MB Widmer, PA Taylor, DA Vallera

Blood (1992) 80 (6): 1614–1622.

https://doi.org/10.1182/blood.V80.6.1614.1614

Published: 1992

NARROW

Murine gamma/delta-expressing T cells affect alloengraftment via the recognition of nonclassical major histocompatibility complex class Ib antigens

In vivo inhibition of cytokine responsiveness and graft-versus-host disease mortality by rapamycin leads to a clinical-pathological syndrome discrete from that observed with cyclosporin A

Lethal murine graft-versus-host disease induced by donor gamma/delta expressing T cells with specificity for host nonclassical major histocompatibility complex class Ib antigens

Therapy for ongoing graft-versus-host disease induced across the major or minor histocompatibility barrier in mice with anti-CD3F(ab')2-ricin toxin A chain immunotoxin

In utero transfer of adult bone marrow cells into recipients with severe combined immunodeficiency disorder yields lymphoid progeny with T- and B-cell functional capabilities

Coblockade of the LFA1:ICAM and CD28/CTLA4:B7 pathways is a highly effective means of preventing acute lethal graft-versus-host disease induced by fully major histocompatibility complex-disparate donor grafts

Interleukin-10 administration decreases survival in murine recipients of major histocompatibility complex disparate donor bone marrow grafts

Adult bone marrow-derived pluripotent hematopoietic stem cells are engraftable when transferred in utero into moderately anemic fetal recipients

In vivo blockade of CD28/CTLA4: B7/BB1 interaction with CTLA4-Ig reduces lethal murine graft-versus-host disease across the major histocompatibility complex barrier in mice

Rapamycin, a potent inhibitor of T-cell function, prevents graft rejection in murine recipients of allogeneic T-cell-depleted donor marrow [published erratum appears in Blood 1994 Jun 1;83(11):3424-5]

Promotion of murine marrow alloengraftment and hematopoietic recovery across the major histocompatibility barrier by administration of recombinant human interleukin-1 alpha [see comments]

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only